Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Walmart, Chevron, Adobe rise premarket; Johnson & Johnson, Carvana fall

Published 07/31/2023, 08:02 PM
© Reuters.
CVX
-
ADBE
-
WMT
-
JNJ
-
DGX
-
W
-
CVNA
-
SOFI
-

Investing.com -- U.S. futures edged higher Monday, at the start of a week that includes more earnings from tech giants as well as the important monthly jobs report.

Here are some of the biggest premarket U.S. stock movers today:

  • Walmart (NYSE:WMT) stock rose 0.3% after the Wall Street Journal reported that the retail giant has further cemented its interest in Flipkart through a $1.4 billion purchase of shares from a major investor in the Indian e-commerce group.

  • Johnson & Johnson (NYSE:JNJ) stock fell 1.7% after a U.S. judge dismissed the drugmaker's second attempt to resolve tens of thousands of lawsuits over its talc products.

  • Chevron (NYSE:CVX) stock rose 1.6% after Goldman Sachs upgraded its stance on the oil major to ‘Buy’ from ‘Neutral’, seeing the potential for strong future growth.

  • Adobe (NASDAQ:ADBE) stock rose 2.5% after Morgan Stanley upgraded the computer software company to ‘Overweight’ from ‘Equal weight’, citing potential upside from Generative AI.

  • Carvana (NYSE:CVNA) stock fell 1.5% after Jefferies downgraded the online used car retailer to ‘Underperform’ from Hold’, saying the company’s current tailwinds aren’t sustainable.

  • SoFi Technologies (NASDAQ:SOFI) stock rose 3.7% after the online personal finance company easily beat revenue expectations in its second quarter, while reporting a narrower-than-expected loss.

  • Wayfair (NYSE:W) stock rose 8.2% after Piper Sandler upgraded the e-commerce company to ‘Overweight’ from 'Neutral', citing improving sales, rising market share, and an attractive valuation.

  • Quest Diagnostics (NYSE:DGX) stock rose 0.5% after the medical laboratories company launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.